Search Results - "Palloni, Andrea"

Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy in Hepatocellular Carcinoma: Where Do We Stand? by Rizzo, Alessandro, Ricci, Angela Dalia, Di Federico, Alessandro, Frega, Giorgio, Palloni, Andrea, Tavolari, Simona, Brandi, Giovanni

“…Hepatocellular carcinoma (HCC) remains the sixth most commonly diagnosed malignancy worldwide, still representing an important cause of cancer-related death…”
Get full text

Improvements in Systemic Therapies for Advanced Malignant Mesothelioma by Deiana, Chiara, Fabbri, Francesca, Tavolari, Simona, Palloni, Andrea, Brandi, Giovanni

“…Malignant pleural mesothelioma (MPM) is a rare and aggressive malignancy associated with poor prognosis and a 5-year survival rate of 12%. Many drugs have been…”
Get full text

Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept by De Lorenzo, Stefania, Tovoli, Francesco, Barbera, Maria Aurelia, Garuti, Francesca, Palloni, Andrea, Frega, Giorgio, Garajovà, Ingrid, Rizzo, Alessandro, Trevisani, Franco, Brandi, Giovanni

“…There is a relative lack of evidence about systemic treatments in patients with hepatocellular carcinoma (HCC) and moderate liver dysfunction (Child-Pugh B)…”
Get full text

Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience by Brandi, Giovanni, Rizzo, Alessandro, Dall'Olio, Filippo Gustavo, Felicani, Cristina, Ercolani, Giorgio, Cescon, Matteo, Frega, Giorgio, Tavolari, Simona, Palloni, Andrea, De Lorenzo, Stefania, Abbati, Francesca, Mollica, Veronica, Ricci, Angela Dalia, Serra, Carla

“…Very few data are available in literature about the role of radiofrequency ablation (RFA) in intrahepatic cholangiocarcinoma (ICC) and previous studies are…”
Get full text

Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes by Di Federico, Alessandro, Mosca, Mirta, Pagani, Rachele, Carloni, Riccardo, Frega, Giorgio, De Giglio, Andrea, Rizzo, Alessandro, Ricci, Dalia, Tavolari, Simona, Di Marco, Mariacristina, Palloni, Andrea, Brandi, Giovanni

“…The advent of immunotherapy and targeted therapies has dramatically changed the outcomes of patients affected by many malignancies. Pancreatic cancer (PC)…”
Get full text

Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies by Brandi, Giovanni, Relli, Valeria, Deserti, Marzia, Palloni, Andrea, Indio, Valentina, Astolfi, Annalisa, Serravalle, Salvatore, Mattiaccio, Alessandro, Vasuri, Francesco, Malvi, Deborah, Deiana, Chiara, Pantaleo, Maria Abbondanza, Cescon, Matteo, Rizzo, Alessandro, Katoh, Masaru, Tavolari, Simona

“…FGFR inhibitors have been developed to inhibit FGFR activation and signal transduction; notwithstanding, currently the selection of intrahepatic…”
Get full text

Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot study by Vasuri, Francesco, Deserti, Marzia, Corradini, Angelo G., Tavolari, Simona, Relli, Valeria, Palloni, Andrea, Frega, Giorgio, Curti, Stefania, Mattioli, Stefano, Cescon, Matteo, D’Errico, Antonia, Brandi, Giovanni

“…Intrahepatic cholangiocarcinoma (iCCA) is a rare malignancy, recently classified in small duct and large duct morphological subtypes. Growing evidence suggests…”
Get full text

Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue by Brandi, Giovanni, Deiana, Chiara, Galvani, Linda, Palloni, Andrea, Ricci, Angela Dalia, Rizzo, Alessandro, Tavolari, Simona

“…Despite representing some of the most common and investigated molecular changes in intrahepatic cholangiocarcinoma (iCCA), the prognostic role of FGFR and…”
Get full text

Hacking Pancreatic Cancer: Present and Future of Personalized Medicine by Di Federico, Alessandro, Tateo, Valentina, Parisi, Claudia, Formica, Francesca, Carloni, Riccardo, Frega, Giorgio, Rizzo, Alessandro, Ricci, Dalia, Di Marco, Mariacristina, Palloni, Andrea, Brandi, Giovanni

“…Pancreatic cancer (PC) is a recalcitrant disease characterized by high incidence and poor prognosis. The extremely complex genomic landscape of PC has a deep…”
Get full text

How to Choose Between Percutaneous Transhepatic and Endoscopic Biliary Drainage in Malignant Obstructive Jaundice: An Updated Systematic Review and Meta-analysis by RIZZO, ALESSANDRO, RICCI, ANGELA DALIA, FREGA, GIORGIO, PALLONI, ANDREA, DE LORENZO, STEFANIA, ABBATI, FRANCESCA, MOLLICA, VERONICA, TAVOLARI, SIMONA, DI MARCO, MARIACRISTINA, BRANDI, GIOVANNI

“…BACKGROUND/AIMMalignant obstructive jaundice (MOJ) is a common condition caused by several primary and secondary cancers. We performed a systematic review and…”
Get full text

Non-Coding RNAs as Predictive Biomarkers to Current Treatment in Metastatic Colorectal Cancer by Garajová, Ingrid, Ferracin, Manuela, Porcellini, Elisa, Palloni, Andrea, Abbati, Francesca, Biasco, Guido, Brandi, Giovanni

“…The onset and selection of resistant clones during cancer treatment with chemotherapy or targeted therapy is a major issue in the clinical management of…”
Get full text

Is post‐transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases? by Brandi, Giovanni, Ricci, Angela Dalia, Rizzo, Alessandro, Zanfi, Chiara, Tavolari, Simona, Palloni, Andrea, De Lorenzo, Stefania, Ravaioli, Matteo, Cescon, Matteo

“…A restaging computed tomography (CT) scan showed a liver-limited disease progression, so the patient received a second chemotherapeutic treatment with FOLFIRI…”
Get full text

Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future Challenges by Rizzo, Alessandro, Federico, Alessandro Di, Ricci, Angela Dalia, Frega, Giorgio, Palloni, Andrea, Pagani, Rachele, Tavolari, Simona, Marco, Mariacristina Di, Brandi, Giovanni

“…Background: Biliary tract cancers (BTCs) represent a heterogeneous group of aggressive solid tumors with limited therapeutic options, and include gallbladder…”
Get full text

Intensive Follow-Up Program and Oncological Outcomes of Biliary Tract Cancer Patients after Curative-Intent Surgery: A Twenty-Year Experience in a Single Tertiary Medical Center by Rizzo, Alessandro, Carloni, Riccardo, Frega, Giorgio, Palloni, Andrea, Di Federico, Alessandro, Ricci, Angela Dalia, De Luca, Raffaele, Tavolari, Simona, Brandi, Giovanni

“…Aim. The aim of this research was to assess the impact of an intensive follow-up program on BTC patients who had received surgery with curative intent at a…”
Get full text

The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of Cholangiocarcinoma by Palloni, Andrea, Bisello, Silvia, Maggio, Ilaria, Massucci, Maria, Galuppi, Andrea, Di Federico, Alessandro, Rizzo, Alessandro, Ricci, Angela Dalia, Siepe, Giambattista, Morganti, Alessio Giuseppe, Brandi, Giovanni, Frega, Giorgio

“…(1) Background: Biliary tract cancers (BTCs) are a heterogeneous group of neoplasms with dismal prognosis and the role of adjuvant chemoradiotherapy in…”
Get full text

Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster by Brandi, Giovanni, Rizzo, Alessandro, Deserti, Marzia, Relli, Valeria, Indio, Valentina, Bin, Sofia, Pariali, Milena, Palloni, Andrea, De Lorenzo, Stefania, Tovoli, Francesco, Tavolari, Simona

“…Polymorphisms in genes modulating xenobiotics metabolism, in particular the ABCC2 c.3972C > T single nucleotide polymorphism (SNP) at exon 28, have been…”
Get full text

Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements by Frega, Giorgio, Palloni, Andrea, Di Pasquale, Giuseppe, Saccoccio, Gioconda, Rizzo, Alessandro, Poluzzi, Elisabetta, Iannone, Primiano, Brandi, Giovanni

Get full text

Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study by Rizzo, Alessandro, Salati, Massimiliano, Frega, Giorgio, Merz, Valeria, Caputo, Francesco, Di Federico, Alessandro, Palloni, Andrea, Carloni, Riccardo, Ricci, Angela Dalia, Gadaleta-Caldarola, Gennaro, Messina, Carlo, Spallanzani, Andrea, Gelsomino, Fabio, Benatti, Stefania, Luppi, Gabriele, Melisi, Davide, Dominici, Massimo, Brandi, Giovanni

“…Objectives: The ABC-06 and the NIFTY trials recently established the role of second-line chemotherapy (2L) in patients with advanced biliary tract cancer…”
Get full text

Membrane Localization of Human Equilibrative Nucleoside Transporter 1 in Tumor Cells May Predict Response to Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients by Brandi, Giovanni, Deserti, Marzia, Vasuri, Francesco, Farioli, Andrea, Degiovanni, Alessio, Palloni, Andrea, Frega, Giorgio, Barbera, Maria A., Lorenzo, Stefania, Garajova, Ingrid, Di Marco, Mariacristina, Pinna, Antonio D., Cescon, Matteo, Cucchetti, Alessandro, Ercolani, Giorgio, D'Errico‐Grigioni, Antonietta, Pantaleo, Maria A., Biasco, Guido, Tavolari, Simona, Aprile, Guiseppe, Cereda, Stefano, Fornaro, Lorenzo, Leone, Francesco, Lonardi, Sara, Santini, Daniele, Silvestris, Nicola, Vasile, Enrico

“…Background. The use of gemcitabine as an adjuvant modality for cholangiocarcinoma (CC) is increasing, but limited data are available on predictive biomarkers…”
Get full text

Prognostic value of integrated morphofunctional imaging methods in inoperable intrahepatic cholangiocarcinoma by Nanni, Cristina, Mosconi, Cristina, Dragonetti, Valentino, Barakat, Massimo, Fraccascia, Nicola, Cocozza, Maria Adriana, Brocchi, Stefano, Palloni, Andrea, Paccapelo, Alexandro, Brandi, Giovanni, Fanti, Stefano

“…Intrahepatic cholangiocarcinoma (iCCA) is a disease characterized by rarity, heterogeneity, and high mortality, where surgical resection is often not possible…”
Get full text